3-D Matrix Stock

3-D Matrix ROE

The Return on Equity (ROE) of 3-D Matrix (7777.T) as of Aug 14, 2026 is -112.86 %. In the previous year, Return on Equity (ROE) was -72.32 % — a change of 56.06% (lower).

ROE

-112.86 %

YoY

56.06%

Last updated:

In 2026, 3-D Matrix's return on equity (ROE) was -112.86 %, a 56.06% increase from the -72.32 % ROE in the previous year.

Access this data via the Eulerpool API

3-D Matrix Stock analysis

What does 3-D Matrix do? 3-D Matrix Ltd is a company specialized in the development and manufacturing of innovative products in the field of biotechnology. Since its founding in 1998, the company has gained recognition for its outstanding research and development results and is now one of the leading companies in the industry. The history of 3-D Matrix Ltd began in 1998 when a group of scientists from Japan made a groundbreaking discovery in the field of materials science. They discovered that a certain material has a unique structure that allows cells and tissues to be cultivated in a more natural way than was previously possible. This discovery formed the basis for the founding of 3-D Matrix Ltd. The business model of 3-D Matrix Ltd is to use its innovative technology and unique products in various areas of biotechnology. The company's three main divisions are regenerative medicine, cell culture, and medical devices. In the field of regenerative medicine, 3-D Matrix Ltd is working to improve the healing of tissue damage and diseases. The company has developed a range of products that enable the effective and natural regeneration of the body's own cells and tissues. These products are used in the treatment of various diseases such as diabetes, arthritis, or tumors. In the cell culture division, 3-D Matrix Ltd offers products that enable cells to be cultured in a natural and effective way. The company has developed a range of innovative cell culture products that allow cells to be grown in a three-dimensional environment that closely resembles the natural environment in the body. These products are used in drug research and development, vaccine production, and personalized medicine. In the medical devices division, 3-D Matrix Ltd offers a range of products that are used in the performance of medical procedures. These products have been developed to improve the safety and effectiveness of medical procedures while reducing recovery time. These include products such as collagen membranes, collagen sponges, and brushes, which are used in plastic surgery, dentistry, and orthopedics. Some of the products offered by 3-D Matrix Ltd include collagen membranes, collagen sponges, collagen brushes, collagen fibrils, and collagen hydrogels. All of these products have been developed using 3-D Matrix Ltd's unique material technology and provide a natural and effective solution for a variety of medical applications. In conclusion, 3-D Matrix Ltd is a company dedicated to the development and manufacturing of innovative products in the field of biotechnology. The company has developed a unique technology that allows for the natural and effective cultivation and regeneration of cells and tissues. The products of 3-D Matrix Ltd are used in various areas of biotechnology, such as regenerative medicine, cell culture, and medical devices, and provide a natural and effective solution for a variety of medical applications. 3-D Matrix is one of the most popular companies on Eulerpool.

ROE Details

Decoding 3-D Matrix's Return on Equity (ROE)

3-D Matrix's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing 3-D Matrix's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

3-D Matrix's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in 3-D Matrix’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about 3-D Matrix stock

Return on Equity (ROE) of 3-D Matrix is -112.86 % in 2026.

Return on Equity (ROE) of 3-D Matrix changed from -72.32 % to -112.86 %, representing a 56.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) 3-D Matrix since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s 3-D Matrix with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — 3-D Matrix

All Key Metrics — 3-D Matrix